NOREEN RUSSO: Open Payments
NPI 1952508046 · WEST END, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,831 in 137 payments from 16 companies in 2025. Trend: 2023 $1,866 · 2024 $3,099 · 2025 $2,831
Food & beverage: $2,776Education: $55
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 40 | $573 |
| Janssen Biotech, Inc. | 10 | $390 |
| Novartis Pharmaceuticals Corporation | 14 | $312 |
| ABBVIE INC. | 18 | $286 |
| UCB, Inc. | 12 | $264 |
| GlaxoSmithKline, LLC. | 10 | $209 |
| Fresenius Kabi USA, LLC | 7 | $157 |
| Lilly USA, LLC | 7 | $141 |
| Organon LLC | 5 | $134 |
| AstraZeneca Pharmaceuticals LP | 2 | $127 |
Products named: TREMFYA, COSENTYX, Bimzelx, BENLYSTA, EVENITY, ENBREL, SKYRIZI, SAPHNELO.
Industry payments across NC — which companies pay providers there.
